Particle.news

Download on the App Store

Monica Seles Discloses Three-Year Battle With Myasthenia Gravis Ahead of U.S. Open

Partnering with immunology firm Argenx’s Go for Greater initiative, she aims to raise public understanding of diagnostic hurdles posed by the rare neuromuscular disease

Image
Image
Image

Overview

  • Monica Seles publicly revealed this week that she has been living with myasthenia gravis since a 2022 diagnosis after experiencing fluctuating symptoms for roughly three years.
  • She first noticed double vision, muscle weakness and fatigue around 2019, prompting further evaluation when routine tasks like hairstyling became difficult.
  • Diagnosis of myasthenia gravis typically involves neurological exams, blood tests for specific autoantibodies and sometimes electrophysiologic studies to detect impaired neuromuscular transmission.
  • Although there is no cure, treatment options range from immunosuppressive medications and intravenous immunoglobulin to newer complement inhibitors or thymectomy, with rare cases risking respiratory failure in a myasthenic crisis.
  • As Argenx’s Go for Greater spokesperson, Seles plans U.S. Open appearances to bolster patient advocacy and broaden public awareness of life with the condition.